CMS issued its final 2025 Medicare Advantage and Part D rule April 4, setting new standards around marketing, broker payments, and prior authorization.

Clover Health CEO Andrew Toy feels good about CMS' 2025 Medicare Advantage rates. 

CareFirst BlueCross BlueShield is offering space in its Baltimore headquarters for Small Business Administration employees assisting business owners in the wake of the Francis Scott Key Bridge collapse. 

From CEO to COO, these are seven moves from top executives that have taken place this year across UnitedHealth Group's core lines of business:

Medicare Advantage plans saw utilization rates rise 8.1% in the fourth quarter of 2023, primarily driven by outpatient and emergency room services, according to an AHIP survey.

UnitedHealthcare has named Robert (Bobby) Hunter as president of its Medicare business.

Nearly 600,000 New Jersey state and public school employees, along with their dependents, now have the choice to enroll in health plans offered by Aetna and Horizon Blue Cross Blue Shield of New Jersey.

Optum could soon purchase Steward's physician group, a clinic chain in Oregon and home health provider Amedisys.

The parent company of Harvard Pilgrim Health Care and Tufts Health Plan is updating prior authorization for home health services as it conducts a larger review of its requirements. 

From Vanguard Group acquiring the sale of its scrapped East Coast campus, to completing the sale of its U.K. companies, here are eight updates on Centene that Becker's has reported since Feb. 6: 

CMS finalized several proposed changes to regulations for the ACA marketplace in 2025. 

CMS has finalized a slight decrease in Medicare Advantage benchmark payments for 2025, despite large insurers reporting rising costs and utilization among MA members.

Aetna has named Ali Khan, MD, as chief medical officer for Medicare and dual-eligible beneficiaries. 

Investment income drove a $377 million net income for Independence Blue Cross in 2023. 

Cigna and Toledo, Ohio-based ProMedica are out of network as of April 1. 

Investment advisory firm Vanguard Group is acquiring the Charlotte, N.C.-based office campus that was once planned to be Centene's East Coast headquarters, the Charlotte Business Journal reported April 2. 

Medicare total spending hit $5.7 billion in 2022 after rebates for GLP-1 drugs such as Ozempic, Wegovy and Mounjaro, up from $57 million in 2018, according to a March 22 KFF analysis.

A federal judge has ruled that the Blue Cross Blue Shield Association and BCBS Michigan must face a lawsuit from Ford Motor Co. over an alleged antitrust conspiracy among Blues plans to fix healthcare prices, thereby overcharging Ford for health insurance provided to its employees.

Wegovy was approved in March to reduce the risk of heart attack and stroke in adults with heart disease, paving the way for Medicare coverage of weight loss drugs. Now, healthcare policy experts anticipate monthly premiums for millions of Medicare enrollees could increase by 2026, though the amount by which prices may jump remains to be seen. 

CMS finalized a slight decrease in Medicare Advantage benchmark payments for 2025.